Skip to main content
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. — Investor Relations & Filings

Ticker · NVCT ISIN · US67080T1088 US Manufacturing
Filings indexed 248 across all filing types
Latest filing 2025-10-31 Director's Dealing
Country US United States of America
Listing US NVCT

About Nuvectis Pharma, Inc.

https://nuvectis.com/

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines and novel targeted therapeutics for the treatment of cancer. The company aims to address serious conditions with unmet medical needs within oncology. Its development pipeline includes the product candidate NXP800.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2025-10-31 English
OWNERSHIP DOCUMENT
Director's Dealing
2025-10-31 English
OWNERSHIP DOCUMENT
Director's Dealing
2025-10-29 English
FORM 8-K
Regulatory Filings
2025-09-25 English
10-Q
Interim / Quarterly Report Q2 2025
2025-08-05 English
FORM 8-K
Regulatory Filings
2025-08-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.